Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23544125 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed LDL Receptor Under Ezetimibe and Simvastatin
Condition: Healthy Men
Interventions: Drug: ezetimibe;   Drug: simvastatin;   Drug: ezetimibe plus simvastatin

Indicates status has not been verified in more than two years